Page 31 - AN-4-4
P. 31

Advanced Neurology                                                   Graphene quantum dots approach in AD



            these functionalization strategies can be used in the design   9. Conclusion
            and development of GQDs for diagnosis and preventative
            intervention of AD, as they can increase binding affinity   The application of GQDs to improve the  progression
            and specificity. 22,94,95  The regulation of Aβ aggregation is a   of AD by disintegrating the NFTs of tau protein holds
            major area in targeting AD pathology. 96,97  Several studies   promising therapeutic potential in AD research. However,
                                                               the limitations associated with their long-term exposure to
            have investigated the experimental application of GQDs   the brain must be thoroughly investigated, and potential
            and their  potential, particularly in  functionalized form,   side effects of GQDs should be minimized through a
            in the regulation of amyloid-forming aggregation.  One   multidisciplinary translational neuroscience approach for
                                                     98
            significant finding is that GQDs exhibit the potential to   therapeutic applications in clinical trials.
            penetrate the blood–brain barrier and prevent protein
            aggregation and α-synuclein fibrillation.  Moreover, Liu   Acknowledgments
                                             99
            et al.  demonstrated the positive modulation of Aβ using
                100
            GQDs, highlighting their positive role in preventing the   None.
            formation of  amyloid  proteins. These  findings  highlight   Funding
            the promising potential GQDs hold for AD diagnosis and
            treatment therapy, warranting further investigation into   None.
            their clinical applications.
                                                               Conflict of interest
            8.3. Challenges and future directions
                                                               The authors declare they have no competing interests.
            GQDs hold tremendous promise as a clinical intervention
            tool. However, several challenges remain in the application   Author contributions
            of GQDs. One major concern is their potential toxicity, as   Conceptualization:  Gideon Sorlelodum Alex, Adejoke
            GQDs could cause major health risks and environmental   Elizabeth Memudu, Tolulope Judah Gbayisomore
            hazards. The use of biocompatible ligands or polymers to   Visualization: Glory Farounbi, Martina Anene-Ogbe
            alter the core–shell structure of GQDs is an effective way   Writing – original draft: All authors
            to reduce their potential toxicity, lessening the detrimental   Writing – review & editing: All authors
            consequences of poisoning.  Another significant
                                     101
            challenge is the high manufacturing cost of GQDs, which   Ethics approval and consent to participate
            it expensive and with limited production yield. Less than   Not applicable.
            30% of the weight is produced by the majority of top-down
            and bottom-up synthesis methods used for GQDs.  These   Consent for publication
                                                    102
            methods require high manufacturing costs and time-
            consuming purification processes. Thus, future research   Not applicable.
            on GQDs should focus on improving manufacturing    Availability of data
            yield, photoluminescence quantum yield, and purification
            techniques to make GQDs cost-effective for use. The   Not applicable.
            production of homogenous, high-quality GQDs with
            consistent optical properties remains a major challenge.   References
            Under inappropriate synthesis conditions, such as high   1.   Stepanchuk AA,  Morgan  ML,  Joseph  JT,  Stys PK.  Dual-
            temperatures and pressure, GQDs could mix and form    probe fluorescence spectroscopy for sensitive quantitation of
            undesirable byproducts, affecting their optical properties   Alzheimer’s amyloid pathology. Acta Neuropathol Commun.
            and stability. However, the advancement of microwave-  2022;10(1):153.
            assisted synthesis can shorten the synthesis period and      doi: 10.1186/s40478-022-01456-y
            increase the yield of GQDs. While carbon-based QDs   2.   Armstrong RA. The molecular biology of senile plaques
            (CQDs) have garnered interest due to their potential for   and neurofibrillary tangles in Alzheimer’s disease.  Folia
            bioimaging and diagnostic applications, developing CQDs   Neuropathol. 2009;47(4):289-299.
            with long-wavelength emission and versatility in imaging
            modalities remains a significant challenge. To overcome   3.   Alzheimer’s Association. 2014 Alzheimer’s disease facts and
                                                                  figures. Alzheimers Dement. 2014;10(2):e47-e92.
            this, scientists have developed hydrothermally produced
            bismuth- and gadolinium-coated CQDs, which can exhibit      doi: 10.1016/j.jalz.2014.02.001
            fluorescence in a variety of colors, making them useful for   4.   Javaid SF, Giebel C, Khan MA, Hashim MJ. Epidemiology
            cell imaging. 103                                     of Alzheimer’s disease and other dementias: Rising global


            Volume 4 Issue 4 (2025)                         25                               doi: 10.36922/an.7087
   26   27   28   29   30   31   32   33   34   35   36